PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS/FTD neurons

Carmelo Milioto(UK Dementia Research Institute), Mireia Carcolé(UK Dementia Research Institute), Ashling Giblin(UK Dementia Research Institute), Rachel Coneys(UK Dementia Research Institute), Olivia N. Attrebi(UK Dementia Research Institute), Mhoriam Ahmed(National Hospital for Neurology and Neurosurgery), Sam Harris(UK Dementia Research Institute), Byung Il Lee(UK Dementia Research Institute), Mengke Yang(UK Dementia Research Institute), Robert Ellingford(UK Dementia Research Institute), Raja Sekhar Nirujogi(University of Dundee), Daniel Biggs(Centre for Human Genetics), Sally Salomonsson(UK Dementia Research Institute), Matteo Zanovello(National Hospital for Neurology and Neurosurgery), Paula de Oliveira(UK Dementia Research Institute), Eszter Katona(UK Dementia Research Institute), Idoia Glaria(UK Dementia Research Institute), Alla Mikheenko(UK Dementia Research Institute), Bethany Geary(University of Dundee), Evan Udine(Mayo Clinic in Florida), Deniz Vaizoglu(UK Dementia Research Institute), Sharifah Anoar(MRC Unit for Lifelong Health and Ageing), Khrisha Jotangiya(UK Dementia Research Institute), Gerard Crowley(UK Dementia Research Institute), Demelza Smeeth(UK Dementia Research Institute), Mirjam L. Adams(UK Dementia Research Institute), Teresa Niccoli(MRC Unit for Lifelong Health and Ageing), Rosa Rademakers(University of Antwerp), Marka van Blitterswijk(Mayo Clinic in Florida), Anny Devoy(King's College London), Soyon Hong(UK Dementia Research Institute), Linda Partridge(MRC Unit for Lifelong Health and Ageing), Alyssa N. Coyne(Johns Hopkins University), Pietro Fratta(National Hospital for Neurology and Neurosurgery), Dario R. Alessi(University of Dundee), Benjamin Davies(Centre for Human Genetics), Marc Aurel Busche(UK Dementia Research Institute), Linda Greensmith(National Hospital for Neurology and Neurosurgery), Elizabeth Fisher(Queen Mary University of London), Adrian M. Isaacs(Queen Mary University of London)
Nature Neuroscience
February 29, 2024
Cited by 38Open Access
Full Text

Abstract

Dipeptide repeat proteins are a major pathogenic feature of C9orf72 amyotrophic lateral sclerosis (C9ALS)/frontotemporal dementia (FTD) pathology, but their physiological impact has yet to be fully determined. Here we generated C9orf72 dipeptide repeat knock-in mouse models characterized by expression of 400 codon-optimized polyGR or polyPR repeats, and heterozygous C9orf72 reduction. (GR)400 and (PR)400 knock-in mice recapitulate key features of C9ALS/FTD, including cortical neuronal hyperexcitability, age-dependent spinal motor neuron loss and progressive motor dysfunction. Quantitative proteomics revealed an increase in extracellular matrix (ECM) proteins in (GR)400 and (PR)400 spinal cord, with the collagen COL6A1 the most increased protein. TGF-β1 was one of the top predicted regulators of this ECM signature and polyGR expression in human induced pluripotent stem cell neurons was sufficient to induce TGF-β1 followed by COL6A1. Knockdown of TGF-β1 or COL6A1 orthologues in polyGR model Drosophila exacerbated neurodegeneration, while expression of TGF-β1 or COL6A1 in induced pluripotent stem cell-derived motor neurons of patients with C9ALS/FTD protected against glutamate-induced cell death. Altogether, our findings reveal a neuroprotective and conserved ECM signature in C9ALS/FTD.


Related Papers

No related papers found

Powered by citation graph analysis